SA PRO
Free Account
Merck & Co., Inc.MRKNYSE
LOADING
|||
OverviewNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 72% recommend buying.

Consensus Rating
Buy
25 analysts·High coverage
72%
Rating Distribution
Strong Buy
00%
Buy
1872%
Hold
624%
Sell
14%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 7% higher.

Bear Case
$90.00
-19%
Consensus
$118.78
+7%
Bull Case
$135.00
+22%
Price Range25 analysts
Low
Consensus
High
$90.00
$135.00
Current Target
Current Price
$110.53
Upside to Target
$8.25

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Beat rate:92%(11/12 quarters)
Avg surprise:+15.8%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 8, 2026Wolfe Research
Merck upgraded to Outperform from Peer Perform at Wolfe Research
Target:$135.00
+24.3%from $108.59
Jan 7, 2026UBS
Merck price target raised to $130 from $105 at UBS
Target:$130.00
+17.2%from $110.96
Dec 18, 2025BMO Capital
Merck upgraded to Outperform from Market Perform at BMO Capital
Target:$130.00
+31.0%from $99.21
Dec 12, 2025Morgan Stanley
Merck price target raised to $102 from $100 at Morgan Stanley
Target:$102.00
+1.9%from $100.06
Dec 10, 2025HSBC
Merck price target raised to $120 from $100 at HSBC
Target:$120.00
+23.9%from $96.89
Dec 5, 2025Guggenheim
Merck price target raised to $122 from $104 at Guggenheim
Target:$122.00
+20.9%from $100.89
Dec 4, 2025Scotiabank
Merck price target raised to $120 from $105 at Scotiabank
Target:$120.00
+17.8%from $101.88
Dec 2, 2025Goldman Sachs
Merck price target raised to $120 from $92 at Goldman Sachs
Target:$120.00
+17.8%from $101.83
Nov 3, 2025Morgan Stanley
Merck price target raised to $100 from $98 at Morgan Stanley
Target:$100.00
+18.1%from $84.65
Sep 17, 2025Berenberg Bank
Merck downgraded to Hold from Buy at Berenberg
Target:$90.00
+10.9%from $81.14
Jul 10, 2025Morgan Stanley
Merck price target lowered to $98 from $99 at Morgan Stanley
Target:$98.00
+16.1%from $84.39
Apr 25, 2025BMO Capital
Merck price target lowered to $82 from $89 at BMO Capital
Target:$82.00
-0.9%from $82.74
Feb 5, 2025Morgan Stanley
Merck price target lowered to $106 from $113 at Morgan Stanley
Target:$106.00
+16.8%from $90.74
Dec 2, 2024Bernstein
Merck (MRK) PT Lowered to $110 at Bernstein SocGen Group as 'Gardasil overhang continues'
Target:$110.00
+9.2%from $100.69
Nov 15, 2024Jefferies
Merck (MRK) PT Raised to $148 at Jefferies
Target:$148.00
+50.5%from $98.36
Nov 1, 2024BMO Capital
Merck (MRK) PT Lowered to $136 at BMO Capital
Target:$136.00
+33.5%from $101.88
Oct 9, 2024UBS
Merck price target lowered to $136 from $142 at UBS
Target:$136.00
+24.9%from $108.88
Oct 7, 2024Barclays
Merck price target lowered to $140 from $142 at Barclays
Target:$140.00
+27.5%from $109.77
Aug 15, 2024Jefferies
Merck (MRK) PT Lowered to $147 at Jefferies
Target:$147.00
+29.5%from $113.49
Jul 31, 2024UBS
Merck Analysts Slash Their Forecasts After Q2 Results
Target:$142.00
+25.8%from $112.89
Jul 31, 2024Bank of America Securities
Merck price target lowered to $145 from $150 at BofA
Target:$145.00
+25.9%from $115.21
Jun 12, 2024Wells Fargo
Wells Fargo Reiterates Equal Weight Rating on Merck (MRK)
Target:$140.00
+6.8%from $131.05
May 30, 2024BMO Capital
BMO Capital Reiterates Outperform Rating on Merck (MRK)
Target:$148.00
+15.9%from $127.71
Mar 27, 2024Truist Financial
Merck (MRK) PT Raised to $142 at Truist Securities
Target:$142.00
+8.6%from $130.81
Mar 27, 2024Jefferies
Merck (MRK) PT Raised to $145 at Jefferies, 'modeling a strong launch out of the gate' for Winrevair
Target:$145.00
+11.4%from $130.18

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance